chr1-54758839-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_152268.4(PARS2):āc.323A>Gā(p.Glu108Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000166 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.00012 ( 0 hom., cov: 32)
Exomes š: 0.00017 ( 0 hom. )
Consequence
PARS2
NM_152268.4 missense
NM_152268.4 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
PARS2 (HGNC:30563): (prolyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of proline to tRNA molecules. Mutations have been found in this gene in some patients with Alpers syndrome. [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.744
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARS2 | NM_152268.4 | c.323A>G | p.Glu108Gly | missense_variant | 2/2 | ENST00000371279.4 | NP_689481.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARS2 | ENST00000371279.4 | c.323A>G | p.Glu108Gly | missense_variant | 2/2 | 1 | NM_152268.4 | ENSP00000360327 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152204Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
19
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251448Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135906
GnomAD3 exomes
AF:
AC:
32
AN:
251448
Hom.:
AF XY:
AC XY:
22
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000170 AC: 249AN: 1461892Hom.: 0 Cov.: 34 AF XY: 0.000176 AC XY: 128AN XY: 727246
GnomAD4 exome
AF:
AC:
249
AN:
1461892
Hom.:
Cov.:
34
AF XY:
AC XY:
128
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74488
GnomAD4 genome
AF:
AC:
19
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
17
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.323A>G (p.E108G) alteration is located in exon 2 (coding exon 1) of the PARS2 gene. This alteration results from a A to G substitution at nucleotide position 323, causing the glutamic acid (E) at amino acid position 108 to be replaced by a glycine (G). The heterozygous missense change is ultra rare in population databases:_x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the PARS2 c.323A>G alteration was observed in 2 among 13,006 total alleles studied (0.02%). The c.323A>G alteration was observed in 17 out of 121,396 total alleles (0.01%) studied in the Exome Aggregation Consortium (ExAC) database. This variant is reported in the Database of Single Nucleotide Polymorphisms (dbSNP) as rs149840204. Rare missense alleles commonly exhibit a deleterious effect on protein function (Kryukov, 2007; Tennessen, 2012; please note that some variants may appear to be rare due to ethnic underrepresentation in the database)._x000D_ IF USED, PULL THESE INTO REFERENCES:_x000D_ Kryukov GV, et al. (2007) Am J Hum Genet 80:727-739. Tennessen JA, et al. (2012) Science 337(64):64-69. The altered amino acid is conserved throughout evolution:_x000D_ The p.E108 amino acid is highly conserved in available vertebrate species. The alteration is predicted deleterious by in silico models:_x000D_ The p.E108G alteration is predicted to be probably damaging by Polyphen and deleterious by SIFT in silico analyses. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 108 of the PARS2 protein (p.Glu108Gly). This variant is present in population databases (rs149840204, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 520549). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at